- Home
- MGRC vs CNTA Comparison
MGRC vs CNTA Comparison
Compare MGRC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRC
- CNTA
- Stock Information
- Founded
- MGRC 1979
- CNTA 2020
- Country
- MGRC United States
- CNTA United Kingdom
- Employees
- MGRC N/A
- CNTA N/A
- Industry
- MGRC Diversified Commercial Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- MGRC Consumer Discretionary
- CNTA Health Care
- Exchange
- MGRC Nasdaq
- CNTA Nasdaq
- Market Cap
- MGRC 2.8B
- CNTA 2.3B
- IPO Year
- MGRC N/A
- CNTA 2021
- Fundamental
- Price
- MGRC $111.19
- CNTA $23.98
- Analyst Decision
- MGRC Buy
- CNTA Strong Buy
- Analyst Count
- MGRC 2
- CNTA 9
- Target Price
- MGRC $147.50
- CNTA $31.75
- AVG Volume (30 Days)
- MGRC 118.8K
- CNTA 958.7K
- Earning Date
- MGRC 10-23-2025
- CNTA 11-12-2025
- Dividend Yield
- MGRC 1.72%
- CNTA N/A
- EPS Growth
- MGRC N/A
- CNTA N/A
- EPS
- MGRC 5.90
- CNTA N/A
- Revenue
- MGRC $931,222,000.00
- CNTA $15,000,000.00
- Revenue This Year
- MGRC $6.30
- CNTA N/A
- Revenue Next Year
- MGRC $5.24
- CNTA N/A
- P/E Ratio
- MGRC $19.16
- CNTA N/A
- Revenue Growth
- MGRC 4.78
- CNTA 118.88
- 52 Week Low
- MGRC $97.81
- CNTA $9.60
- 52 Week High
- MGRC $129.93
- CNTA $25.31
- Technical
- Relative Strength Index (RSI)
- MGRC 37.71
- CNTA 69.87
- Support Level
- MGRC $111.69
- CNTA $22.50
- Resistance Level
- MGRC $123.20
- CNTA $25.31
- Average True Range (ATR)
- MGRC 2.98
- CNTA 0.77
- MACD
- MGRC -0.48
- CNTA 0.11
- Stochastic Oscillator
- MGRC 21.38
- CNTA 93.06
About MGRC McGrath RentCorp
McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.